Imagine the ocean as a giant, unread library of chemical recipes for skin health. Instead of guessing which pages to read, this project uses AI to scan the library and find the exact 'recipes' for anti-aging and sun protection. Once found, they use lab-grown methods to produce these ingredients without harming the sea.
Traditional marine bioprospecting is too slow and relies on trial-and-error, leading to low discovery rates for new active ingredients. Companies struggle to find sustainable, high-performance alternatives to synthetic chemicals for skincare.
A digital and biotechnological pipeline that uses AI to discover, optimize, and scale up the production of marine bioactive compounds like peptides and terpenes.
If you are a premium skincare brand dealing with the high cost and slow speed of finding new natural active ingredients — this project developed a digital screening and bioproduction pipeline that identifies compounds with anti-inflammatory and UV-protecting effects.
If you are a specialty chemical manufacturer dealing with inefficient trial-and-error extraction from nature — this project developed metabolic engineering tools that allow for the sustainable, lab-based production of marine terpenes and peptides.
If you are a medical-grade skincare SME dealing with the need for safer, sustainable barrier-repair ingredients — this project developed a Safe and Sustainable by Design process to create bioactive molecules for skin barrier protection.
Based on available project data, specific pricing is not provided, but the project aims to deliver cost-effective solutions through biotechnological production.
Yes, the project objective explicitly includes the scale-up and demonstration of production for the identified bioactive compounds.
Based on available project data, specific licensing terms are not listed, but the project is industry-driven with 6 industrial partners involved in the translation to commercial solutions.
The project runs from 2026-06-01 to 2030-05-31, suggesting commercial readiness targets around 2030.
The project focuses on creating formulations with specific effects such as antioxidant and UV-protecting properties for high-value cosmetics.
The consortium is heavily weighted toward commercial application, with a 50% industry ratio consisting of 6 companies, 5 of which are SMEs. This strong industrial presence, combined with partners from 8 countries including New Zealand and the UK, ensures a high capacity for translating lab discoveries into market-ready cosmetic ingredients.
Contact AINIA in Spain
Contact us to track the progress of this marine biotech pipeline.
